▶ 調査レポート

ナルトレキソンHCLの世界市場レポート2020

• 英文タイトル:Global Naltrexone HCL Sales Market Report 2020

QYResearchが調査・発行した産業分析レポートです。ナルトレキソンHCLの世界市場レポート2020 / Global Naltrexone HCL Sales Market Report 2020 / 20QY06-02599資料のイメージです。• レポートコード:20QY06-02599
• 出版社/出版日:QYResearch / 2020年6月1日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、137ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥592,000 (USD4,000)▷ お問い合わせ
  Multi User¥888,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,184,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社の当調査資料では、ナルトレキソンHCLのグローバル市場について種類別(ナルトレキソンHCL、タイプII)、用途別(オピオイド依存症、アルコール依存症、その他)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。

・ナルトレキソンHCL市場の概要
・世界の主要地域別ナルトレキソンHCL市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界のナルトレキソンHCL市場規模2015-2026:種類別(ナルトレキソンHCL、タイプII)
・世界のナルトレキソンHCL市場規模2015-2026:用途別(オピオイド依存症、アルコール依存症、その他)
・ナルトレキソンHCLの北米市場規模2015-2020
・ナルトレキソンHCLのヨーロッパ市場規模2015-2020
・ナルトレキソンHCLの中国市場規模2015-2020
・ナルトレキソンHCLの日本市場規模2015-2020
・ナルトレキソンHCLの東南アジア市場規模2015-2020
・ナルトレキソンHCLのインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(Taj Pharmaceuticals、Freedom Pharmaceuticals、Rusan、Sanofi、IVAX、Faran Shimi、Sun Pharma、Noramco、Haida Taicheng)
・ナルトレキソンHCLの製造コスト分析
・販売チャネル、流通業者、顧客
・ナルトレキソンHCLの市場動向・機会・課題
・調査の結論

Naltrexone HCL is an opioid receptor antagonist used primarily in the management of alcohol dependence and opioid dependence.
Naltrexone HCL is an opioid receptor antagonist used primarily in the management of alcohol dependence and opioid dependence. As a restricted drug, Naltrexone HCL manufacturers are limited. They mainly concentrated in Europe, India, USA and China.
Global naltrexone HCL consumption areas concentrate in Europe, India and USA. Europe is the largest naltrexone HCL consumption area, which took 38.30% in 2015. India also took 21.44% and USA naltrexone HCL consumption took 18.80% of globe.

Market Analysis and Insights: Global Naltrexone HCL Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Naltrexone HCL market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Naltrexone HCL industry.
Based on our recent survey, we have several different scenarios about the Naltrexone HCL YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 20 million in 2019. The market size of Naltrexone HCL will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

Global Naltrexone HCL Scope and Market Size
The global Naltrexone HCL market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Naltrexone HCL market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Naltrexone HCL market is segmented into
Naltrexone HCL
Type II

Segment by Application, the Naltrexone HCL market is segmented into
Opioid Independence
Alcohol Independence
Other

The Naltrexone HCL market is analysed and market size information is provided by regions (countries). Segment by Application, the Naltrexone HCL market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Naltrexone HCL Market Share Analysis
Naltrexone HCL market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Naltrexone HCL business, the date to enter into the Naltrexone HCL market, Naltrexone HCL product introduction, recent developments, etc.

The major vendors covered:
Taj Pharmaceuticals
Freedom Pharmaceuticals
Rusan
Sanofi
IVAX
Faran Shimi
Sun Pharma
Noramco
Haida Taicheng

レポート目次

1 Naltrexone HCL Market Overview
1.1 Naltrexone HCL Product Scope
1.2 Naltrexone HCL Segment by Type
1.2.1 Global Naltrexone HCL Sales by Type (2020-2026)
1.2.2 Naltrexone HCL
1.2.3
1.3 Naltrexone HCL Segment by Application
1.3.1 Global Naltrexone HCL Sales Comparison by Application (2020-2026)
1.3.2 Opioid Independence
1.3.3 Alcohol Independence
1.3.4 Other
1.4 Naltrexone HCL Market Estimates and Forecasts (2015-2026)
1.4.1 Global Naltrexone HCL Sales Growth Rate (2015-2026)
1.4.2 Global Naltrexone HCL Revenue and Growth Rate (2015-2026)
1.4.3 Global Naltrexone HCL Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Naltrexone HCL Industry Impact
1.5.1 How the Covid-19 is Affecting the Naltrexone HCL Industry
1.5.1.1 Naltrexone HCL Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Naltrexone HCL Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Naltrexone HCL Players to Combat Covid-19 Impact

2 Naltrexone HCL Estimate and Forecast by Region
2.1 Global Naltrexone HCL Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Naltrexone HCL Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Naltrexone HCL Sales Market Share by Region (2015-2020)
2.2.2 Global Naltrexone HCL Revenue Market Share by Region (2015-2020)
2.3 Global Naltrexone HCL Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Naltrexone HCL Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Naltrexone HCL Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Naltrexone HCL Estimates and Projections (2015-2026)
2.4.2 Europe Naltrexone HCL Estimates and Projections (2015-2026)
2.4.3 China Naltrexone HCL Estimates and Projections (2015-2026)
2.4.4 Japan Naltrexone HCL Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Naltrexone HCL Estimates and Projections (2015-2026)
2.4.6 India Naltrexone HCL Estimates and Projections (2015-2026)
3 Global Naltrexone HCL Competition Landscape by Players
3.1 Global Top Naltrexone HCL Players by Sales (2015-2020)
3.2 Global Top Naltrexone HCL Players by Revenue (2015-2020)
3.3 Global Naltrexone HCL Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Naltrexone HCL as of 2019)
3.4 Global Naltrexone HCL Average Price by Company (2015-2020)
3.5 Manufacturers Naltrexone HCL Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Naltrexone HCL Players (Opinion Leaders)
4 Global Naltrexone HCL Market Size by Type
4.1 Global Naltrexone HCL Historic Market Review by Type (2015-2020)
4.1.1 Global Naltrexone HCL Sales Market Share by Type (2015-2020)
4.1.2 Global Naltrexone HCL Revenue Market Share by Type (2015-2020)
4.1.3 Global Naltrexone HCL Price by Type (2014-2020)
4.2 Global Naltrexone HCL Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Naltrexone HCL Sales Forecast by Type (2021-2026)
4.2.2 Global Naltrexone HCL Revenue Forecast by Type (2021-2026)
4.2.3 Global Naltrexone HCL Price Forecast by Type (2021-2026)
5 Global Naltrexone HCL Market Size by Application
5.1 Global Naltrexone HCL Historic Market Review by Application (2015-2020)
5.1.1 Global Naltrexone HCL Sales Market Share by Application (2015-2020)
5.1.2 Global Naltrexone HCL Revenue Market Share by Application (2015-2020)
5.1.3 Global Naltrexone HCL Price by Application (2015-2020)
5.2 Global Naltrexone HCL Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Naltrexone HCL Sales Forecast by Application (2021-2026)
5.2.2 Global Naltrexone HCL Revenue Forecast by Application (2021-2026)
5.2.3 Global Naltrexone HCL Price Forecast by Application (2021-2026)

3 North America Naltrexone HCL Market Facts & Figures
3.2 North America Naltrexone HCL Sales Market Share by Company (2015-2020)
3.3 North America Naltrexone HCL Sales Market Share by Type (2015-2020)
3.4 North America Naltrexone HCL Sales Market Share by Application (2015-2020)

4 Europe Naltrexone HCL Market Facts & Figures
4.2 Europe Naltrexone HCL Sales Market Share by Company (2015-2020)
4.3 Europe Naltrexone HCL Sales Market Share by Type (2015-2020)
4.4 Europe Naltrexone HCL Sales Market Share by Application (2015-2020)

5 China Naltrexone HCL Market Facts & Figures
5.2 China Naltrexone HCL Sales Market Share by Company (2015-2020)
5.3 China Naltrexone HCL Sales Market Share by Type (2015-2020)
5.4 China Naltrexone HCL Sales Market Share by Application (2015-2020)

6 Japan Naltrexone HCL Market Facts & Figures
6.2 Japan Naltrexone HCL Sales Market Share by Company (2015-2020)
6.3 Japan Naltrexone HCL Sales Market Share by Type (2015-2020)
6.4 Japan Naltrexone HCL Sales Market Share by Application (2015-2020)

7 Southeast Asia Naltrexone HCL Market Facts & Figures
7.2 Southeast Asia Naltrexone HCL Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Naltrexone HCL Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Naltrexone HCL Sales Market Share by Application (2015-2020)

8 India Naltrexone HCL Market Facts & Figures
8.2 India Naltrexone HCL Sales Market Share by Company (2015-2020)
8.3 India Naltrexone HCL Sales Market Share by Type (2015-2020)
8.4 India Naltrexone HCL Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Naltrexone HCL Business
12.1 Taj Pharmaceuticals
12.1.1 Taj Pharmaceuticals Naltrexone HCL Corporation Information
12.1.2 Taj Pharmaceuticals Naltrexone HCL Business Overview and Total Revenue
12.1.3 Taj Pharmaceuticals Naltrexone HCL Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Taj Pharmaceuticals Naltrexone HCL Products Offered
12.1.5 Taj Pharmaceuticals Recent Development
12.2 Freedom Pharmaceuticals
12.2.1 Freedom Pharmaceuticals Naltrexone HCL Corporation Information
12.2.2 Freedom Pharmaceuticals Naltrexone HCL Business Overview and Total Revenue
12.2.3 Freedom Pharmaceuticals Naltrexone HCL Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Freedom Pharmaceuticals Naltrexone HCL Products Offered
12.2.5 Freedom Pharmaceuticals Recent Development
12.3 Rusan
12.3.1 Rusan Naltrexone HCL Corporation Information
12.3.2 Rusan Naltrexone HCL Business Overview and Total Revenue
12.3.3 Rusan Naltrexone HCL Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Rusan Naltrexone HCL Products Offered
12.3.5 Rusan Recent Development
12.4 Sanofi
12.4.1 Sanofi Naltrexone HCL Corporation Information
12.4.2 Sanofi Naltrexone HCL Business Overview and Total Revenue
12.4.3 Sanofi Naltrexone HCL Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Sanofi Naltrexone HCL Products Offered
12.4.5 Sanofi Recent Development
12.5 IVAX
12.5.1 IVAX Naltrexone HCL Corporation Information
12.5.2 IVAX Naltrexone HCL Business Overview and Total Revenue
12.5.3 IVAX Naltrexone HCL Sales, Revenue and Gross Margin (2015-2020)
12.5.4 IVAX Naltrexone HCL Products Offered
12.5.5 IVAX Recent Development
12.6 Faran Shimi
12.6.1 Faran Shimi Naltrexone HCL Corporation Information
12.6.2 Faran Shimi Naltrexone HCL Business Overview and Total Revenue
12.6.3 Faran Shimi Naltrexone HCL Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Faran Shimi Naltrexone HCL Products Offered
12.6.5 Faran Shimi Recent Development
12.7 Sun Pharma
12.7.1 Sun Pharma Naltrexone HCL Corporation Information
12.7.2 Sun Pharma Naltrexone HCL Business Overview and Total Revenue
12.7.3 Sun Pharma Naltrexone HCL Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Sun Pharma Naltrexone HCL Products Offered
12.7.5 Sun Pharma Recent Development
12.8 Noramco
12.8.1 Noramco Naltrexone HCL Corporation Information
12.8.2 Noramco Naltrexone HCL Business Overview and Total Revenue
12.8.3 Noramco Naltrexone HCL Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Noramco Naltrexone HCL Products Offered
12.8.5 Noramco Recent Development
12.9 Haida Taicheng
12.9.1 Haida Taicheng Naltrexone HCL Corporation Information
12.9.2 Haida Taicheng Naltrexone HCL Business Overview and Total Revenue
12.9.3 Haida Taicheng Naltrexone HCL Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Haida Taicheng Naltrexone HCL Products Offered
12.9.5 Haida Taicheng Recent Development

13 Naltrexone HCL Manufacturing Cost Analysis
13.1 Naltrexone HCL Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Naltrexone HCL
13.4 Naltrexone HCL Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Naltrexone HCL Distributors List
14.3 Naltrexone HCL Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Naltrexone HCL Sales (Kg) Growth Rate by Type (2020-2026)
Table 2. Global Naltrexone HCL Sales (Kg) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Naltrexone HCL Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Naltrexone HCL Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Naltrexone HCL Players to Combat Covid-19 Impact
Table 8. Global Market Naltrexone HCL Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Naltrexone HCL Sales (Kg) by Region (2015-2020)
Table 10. Global Naltrexone HCL Sales Market Share by Region (2015-2020)
Table 11. Global Naltrexone HCL Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Naltrexone HCL Revenue Share by Region (2015-2020)
Table 13. Global Naltrexone HCL Sales (Kg) Forecast by Region (2021-2026)
Table 14. Global Naltrexone HCL Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Naltrexone HCL Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Naltrexone HCL Revenue Share Forecast by Region (2021-2026)
Table 17. Global Naltrexone HCL (Kg) of Key Companies (2015-2020)
Table 18. Global Naltrexone HCL Sales Share by Company (2015-2020)
Table 19. Global Naltrexone HCL Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Naltrexone HCL Revenue Share by Company (2015-2020)
Table 21. Global Naltrexone HCL by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Naltrexone HCL as of 2019)
Table 22. Global Naltrexone HCL Average Price (USD/Kg) of Key Company (2015-2020)
Table 23. Manufacturers Naltrexone HCL Manufacturing Sites and Area Served
Table 24. Manufacturers Naltrexone HCL Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Naltrexone HCL Players
Table 27. Global Naltrexone HCL Sales (Kg) by Type (2015-2020)
Table 28. Global Naltrexone HCL Sales Share by Type (2015-2020)
Table 29. Global Naltrexone HCL Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Naltrexone HCL Price (Kg) by Type (2015-2020)
Table 31. Global Naltrexone HCL Sales Share by Type (2021-2026)
Table 32. Global Naltrexone HCL Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Naltrexone HCL Revenue Share by Type (2021-2026)
Table 34. Global Naltrexone HCL Price (Kg) by Type (2021-2026)
Table 35. Global Naltrexone HCL Sales (Kg) by Application (2015-2020)
Table 36. Global Naltrexone HCL Sales Share by Application (2015-2020)
Table 37. Global Naltrexone HCL Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Naltrexone HCL Price (Kg) by Application (2015-2020)
Table 39. Global Naltrexone HCL Sales (Kg) by Application (2021-2026)
Table 40. Global Naltrexone HCL Sales Share by Application (2021-2026)
Table 41. Global Naltrexone HCL Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Naltrexone HCL Revenue Share by Application (2021-2026)
Table 43. Global Naltrexone HCL Price (Kg) by Application (2021-2026)
Table 44. United States Naltrexone HCL Sales (Kg) by Company (2015-2020)
Table 45. United States Naltrexone HCL Sales Market Share by Company (2015-2020)
Table 46. United States Naltrexone HCL Sales (Kg) by Type (2015-2020)
Table 47. United States Naltrexone HCL Sales Market Share by Type (2015-2020)
Table 48. United States Naltrexone HCL Sales (Kg) by Application (2015-2020)
Table 49. United States Naltrexone HCL Sales Market Share by Application (2015-2020)
Table 50. Europe Naltrexone HCL Sales (Kg) by Company (2015-2020)
Table 51. Europe Naltrexone HCL Sales Market Share by Company (2015-2020)
Table 52. Europe Naltrexone HCL Sales (Kg) by Type (2015-2020)
Table 53. Europe Naltrexone HCL Sales Market Share by Type (2015-2020)
Table 54. Europe Naltrexone HCL Sales (Kg) by Application (2015-2020)
Table 55. Europe Naltrexone HCL Sales Market Share by Type (2015-2020)
Table 56. China Naltrexone HCL Sales (Kg) by Company (2015-2020)
Table 57. China Naltrexone HCL Sales Market Share by Company (2015-2020)
Table 58. China Naltrexone HCL Sales (Kg) by Type (2015-2020)
Table 59. China Naltrexone HCL Sales Market Share by Type (2015-2020)
Table 60. China Naltrexone HCL Sales (Kg) by Application (2015-2020)
Table 61. China Naltrexone HCL Sales Market Share by Application (2015-2020)
Table 62. Japan Naltrexone HCL Sales (Kg) by Company (2015-2020)
Table 63. Japan Naltrexone HCL Sales Market Share by Company (2015-2020)
Table 64. Japan Naltrexone HCL Sales (Kg) by Type (2015-2020)
Table 65. Japan Naltrexone HCL Sales Market Share by Type (2015-2020)
Table 66. Japan Naltrexone HCL Sales (Kg) by Application (2015-2020)
Table 67. Japan Naltrexone HCL Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Naltrexone HCL Sales (Kg) by Company (2015-2020)
Table 69. Southeast Asia Naltrexone HCL Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Naltrexone HCL Sales (Kg) by Type (2015-2020)
Table 71. Southeast Asia Naltrexone HCL Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Naltrexone HCL Sales (Kg) by Type (2015-2020)
Table 73. Southeast Asia Naltrexone HCL Sales Market Share by Application (2015-2020)
Table 74. India Naltrexone HCL Sales (Kg) by Company (2015-2020)
Table 75. India Naltrexone HCL Sales Market Share by Company (2015-2020)
Table 76. India Naltrexone HCL Sales (Kg) by Type (2015-2020)
Table 77. India Naltrexone HCL Sales Market Share by Type (2015-2020)
Table 78. India Naltrexone HCL Sales (Kg) by Application (2015-2020)
Table 79. India Naltrexone HCL Sales Market Share by Application (2015-2020)
Table 80. Taj Pharmaceuticals Corporation Information
Table 81. Taj Pharmaceuticals Description and Business Overview
Table 82. Taj Pharmaceuticals Naltrexone HCL Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 83. Taj Pharmaceuticals Naltrexone HCL Product
Table 84. Taj Pharmaceuticals Recent Development
Table 85. Freedom Pharmaceuticals Corporation Information
Table 86. Freedom Pharmaceuticals Description and Business Overview
Table 87. Freedom Pharmaceuticals Naltrexone HCL Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 88. Freedom Pharmaceuticals Naltrexone HCL Product
Table 89. Freedom Pharmaceuticals Recent Development
Table 90. Rusan Corporation Information
Table 91. Rusan Description and Business Overview
Table 92. Rusan Naltrexone HCL Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 93. Rusan Naltrexone HCL Product
Table 94. Rusan Recent Development
Table 95. Sanofi Corporation Information
Table 96. Sanofi Description and Business Overview
Table 97. Sanofi Naltrexone HCL Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 98. Sanofi Naltrexone HCL Product
Table 99. Sanofi Recent Development
Table 100. IVAX Corporation Information
Table 101. IVAX Description and Business Overview
Table 102. IVAX Naltrexone HCL Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 103. IVAX Naltrexone HCL Product
Table 104. IVAX Recent Development
Table 105. Faran Shimi Corporation Information
Table 106. Faran Shimi Description and Business Overview
Table 107. Faran Shimi Naltrexone HCL Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 108. Faran Shimi Naltrexone HCL Product
Table 109. Faran Shimi Recent Development
Table 110. Sun Pharma Corporation Information
Table 111. Sun Pharma Description and Business Overview
Table 112. Sun Pharma Naltrexone HCL Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 113. Sun Pharma Naltrexone HCL Product
Table 114. Sun Pharma Recent Development
Table 115. Noramco Corporation Information
Table 116. Noramco Naltrexone HCL Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 117. Noramco Description and Business Overview
Table 118. Noramco Naltrexone HCL Product
Table 119. Noramco Recent Development
Table . Haida Taicheng Corporation Information
Table . Haida Taicheng Naltrexone HCL Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table . Haida Taicheng Description and Business Overview
Table . Haida Taicheng Naltrexone HCL Product
Table . Haida Taicheng Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Naltrexone HCL Distributors List
Table 128. Naltrexone HCL Customers List
Table 129. Market Key Trends
Table 130. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 131. Key Challenges
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Naltrexone HCL Product Picture
Figure 2. Global Naltrexone HCL Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Naltrexone HCL Market Share by Application in 2020 & 2026
Figure 6. Opioid Independence Examples
Figure 7. Alcohol Independence Examples
Figure 8. Other Examples
Figure 9. Global Naltrexone HCL Sales (Kg) Growth Rate (2015-2026)
Figure 10. Global Naltrexone HCL Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Naltrexone HCL Price Trends Growth Rate (2015-2026) (USD/Kg)
Figure 12. Global Naltrexone HCL Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Naltrexone HCL Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Naltrexone HCL Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Naltrexone HCL Sales (Kg) Growth Rate (2015-2026)
Figure 16. Europe Naltrexone HCL Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Naltrexone HCL Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Naltrexone HCL Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Naltrexone HCL Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Naltrexone HCL Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Naltrexone HCL Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Naltrexone HCL Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Naltrexone HCL Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Naltrexone HCL Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Naltrexone HCL Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Naltrexone HCL Players Market Share by Revenue in Naltrexone HCL 2015 & 2019
Figure 27. Naltrexone HCL Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Naltrexone HCL Revenue Share by Type (2015-2020)
Figure 29. Global Naltrexone HCL Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Naltrexone HCL Revenue Share by Application (2015-2020)
Figure 31. Global Naltrexone HCL Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Naltrexone HCL Sales Market Share by Type in 2019
Figure 33. United States Naltrexone HCL Sales Market Share by Type in 2019
Figure 34. Europe Naltrexone HCL Sales Market Share by Company in 2019
Figure 35. Europe Naltrexone HCL Sales Market Share by Type in 2019
Figure 36. Europe Naltrexone HCL Sales Market Share by Application in 2019
Figure 37. China Naltrexone HCL Sales Market Share by Company in 2019
Figure 38. China Naltrexone HCL Sales Market Share by Type in 2019
Figure 39. China Naltrexone HCL Sales Market Share by Application in 2019
Figure 40. Japan Naltrexone HCL Sales Market Share by Company in 2019
Figure 41. Japan Naltrexone HCL Sales Market Share by Type in 2019
Figure 42. Japan Naltrexone HCL Sales Market Share by Application in 2019
Figure 43. Southeast Asia Naltrexone HCL Sales Market Share by Company in 2019
Figure 44. Southeast Asia Naltrexone HCL Sales Market Share by Type in 2019
Figure 45. Southeast Asia Naltrexone HCL Sales Market Share by Application in 2019
Figure 46. India Naltrexone HCL Sales Market Share by Company in 2019
Figure 47. India Naltrexone HCL Sales Market Share by Type in 2019
Figure 48. India Naltrexone HCL Sales Market Share by Application in 2019
Figure 49. Taj Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Freedom Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Rusan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. IVAX Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Faran Shimi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Sun Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Noramco Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Haida Taicheng Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Key Raw Materials Price Trend
Figure 59. Manufacturing Cost Structure of Naltrexone HCL
Figure 60. Manufacturing Process Analysis of Naltrexone HCL
Figure 61. Naltrexone HCL Industrial Chain Analysis
Figure 62. Channels of Distribution
Figure 63. Distributors Profiles
Figure 64. Porter's Five Forces Analysis
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed